Learn More
Medchemexpress LLC Imlunestrant | 2408840-26-4 | 100.0% | C29H24F4N2O3 | 250 MG

Supplier: Medchemexpress LLC 250MGHY145572
Imlunestrant is an orally active, potent, and selective estrogen receptor degrader (SERD) with pure antagonistic properties. It leads to sustained inhibition of ER-dependent gene transcription and cell growth, making it suitable for research on ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC).
- Orally active, potent, and selective estrogen receptor degrader (SERD)
- Pure antagonistic properties
- Sustained inhibition of ER-dependent gene transcription and cell growth
- Antiproliferative activity against human MCF7 cells harboring ERalpha Y537N mutant
- Antiproliferative activity against human MCF7 cells harboring wild type ERalpha
- Favorable pharmacokinetic (PK) properties
- Demonstrates antitumor activity in ESR1 mutants
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.